Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease-Reference-Cited by-同舟云学术

Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease

Published:2009-07 Issue:7 Volume:24 Page:1258-1264
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:

Author:

Takatsu Noritaka,Matsui Toshiyuki,Murakami Yuji,Ishihara Hiroshi,Hisabe Takashi,Nagahama Takashi,Maki Shinichirou,Beppu Takahiro,Takaki Yasuhiro,Hirai Fumihito,Yao Kenshi

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2009.05917.x/fullpdf

Reference30 articles.

1. The treatment of chronic ulcerative colitis with 6-mercaptopurine;Bean;Med. J. Aust,1962

2. Controlled trial of azathioprine in Crohn's disease;Rhodes;Lancet,1971

3. Controlled trial of azathioprine in Crohn's disease;Willoughby;Lancet,1971

4. Treatment of Crohn's disease with 6-mercaptopurine: a long-term, randomized, double-blind study;Present;N. Engl. J. Med,1980

5. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial;Jewel;Br. Med. J,1974

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carvedilol alleviates the detrimental effects of azathioprine on hepatic tissues in experimental rats: Focusing on redox system, inflammatory and apoptosis pathways;Human & Experimental Toxicology;2024-01

2. NUDT15Polymorphism and Its Association With Mercaptopurine Hematotoxicity in Acute Lymphoblastic Leukemia in Indonesian Children;In Vivo;2024

3. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

4. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024

5. NLRP3 inflammasome in hepatic diseases: A pharmacological target;Biochemical Pharmacology;2023-11